Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification and Characterization of Two Structurally Related Dipeptides that Enhance Catalytic Efficiency of Neurolysin
Srinidhi Jayaraman, Joanna Kocot, Shiva Hadi Esfahani, et al.
Journal of Pharmacology and Experimental Therapeutics (2021) Vol. 379, Iss. 2, pp. 191-202
Open Access | Times Cited: 11

Showing 11 citing articles:

The Missing Enzymes: A Call to Update Pharmacological Profiling Practices for Better Drug Safety Assessment
Monika Maciąg, Vardan T. Karamyan
Journal of Medicinal Chemistry (2025)
Open Access
The evolution of small molecule enzyme activators
Louise F. Dow, Alfie M. Case, Megan P. Paustian, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 11, pp. 2206-2230
Open Access | Times Cited: 8
Discovery of First-in-Class Peptidomimetic Neurolysin Activators Possessing Enhanced Brain Penetration and Stability
Md. Shafikur Rahman, Shikha Kumari, Shiva Hadi Esfahani, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 17, pp. 12705-12722
Open Access | Times Cited: 13
In-Vivo and Ex-Vivo Brain Uptake Studies of Peptidomimetic Neurolysin Activators in Healthy and Stroke Animals
Saeideh Nozohouri, Shiva Hadi Esfahani, Behnam Noorani, et al.
Pharmaceutical Research (2022) Vol. 39, Iss. 7, pp. 1587-1598
Open Access | Times Cited: 9
Imidazole Bioisostere Activators of Endopeptidase Neurolysin with Enhanced Potency and Metabolic Stability
Md. Shafikur Rahman, Shiva Hadi Esfahani, Yong Zhang, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 4, pp. 510-517
Closed Access | Times Cited: 1
Structural basis of divergent substrate recognition and inhibition of human neurolysin
Ke Shi, Sounak Bagchi, Jordis Bickel, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Discovery of the Next Generation of Non-peptidomimetic Neurolysin Activators with High Blood-Brain Barrier Permeability: a Pharmacokinetics Study in Healthy and Stroke Animals
Yong Zhang, Sejal Sharma, Shirisha Jonnalagadda, et al.
Pharmaceutical Research (2023) Vol. 40, Iss. 11, pp. 2747-2758
Closed Access | Times Cited: 3
Small molecule neurolysin activators, potential multi-mechanism agents for ischemic stroke therapy
Shiva Hadi Esfahani, Thomas J. Abbruscato, Paul C. Trippier, et al.
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 5, pp. 401-404
Open Access | Times Cited: 5
Structure-activity relationship studies of functionalized aromatic peptidomimetics as neurolysin activators
Md. Shafikur Rahman, Shiva Hadi Esfahani, Saeideh Nozohouri, et al.
Bioorganic & Medicinal Chemistry Letters (2022) Vol. 64, pp. 128669-128669
Open Access | Times Cited: 4
Is Diminazene an Angiotensin-Converting Enzyme 2 (ACE2) Activator? Experimental Evidence and Implications
Shiva Hadi Esfahani, Srinidhi Jayaraman, Vardan T. Karamyan
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 383, Iss. 2, pp. 149-156
Open Access | Times Cited: 2
Challenges with the proposed ACE2 activation mechanism of diminazene aceturate
Shiva Hadi Esfahani, Vardan T. Karamyan
Clinical and Experimental Pharmacology and Physiology (2022) Vol. 49, Iss. 5, pp. 608-610
Closed Access
Page 1

Scroll to top